Genomics

Dataset Information

0

CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy. [ATAC-Seq]

ABSTRACT: CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy. [ATAC-Seq]

PROVIDER: PRJNA520908 | ENA |

REPOSITORIES: ENA

Json Xml

Dataset's files

Source:
Action DRS
SRR8528251_1.fastq.gz Fastqsanger.gz
SRR8528251_2.fastq.gz Fastqsanger.gz
SRR8528252_1.fastq.gz Fastqsanger.gz
SRR8528252_2.fastq.gz Fastqsanger.gz
SRR8528253_1.fastq.gz Fastqsanger.gz
Items per page:
1 - 5 of 16

Similar Datasets

Genomics CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy.
| PRJNA520907 | ENA
Genomics CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy [microarray]
| PRJNA564284 | ENA
Genomics CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy. [RNA-Seq]
| PRJNA520909 | ENA
Genomics CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy [ATAC-seq]
| PRJNA564279 | ENA
Genomics CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy [scRNA-seq]
| PRJNA564283 | ENA
Transcriptomics CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy. [RNA-Seq]
2019-12-11 | GSE126071 | GEO
Genomics CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy. [ATAC-Seq]
2019-12-11 | GSE126070 | GEO
Transcriptomics CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy [scRNA-seq]
2019-12-11 | GSE137015 | GEO
Genomics CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy [ATAC-seq]
2019-12-11 | GSE137014 | GEO
Transcriptomics CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy [microarray]
2019-12-11 | GSE137016 | GEO